Verismo Therapeutics

0 followers

Verismo Therapeutics is pioneering the development of novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer, especially non-hematologic malignancies with few effective therapeutic options.

Employees

11-50

Links


Org chart

CEO / Co-founder
Collapse
CSO
Director Of Corporate Development / Start-up Member
Senior Director of MSAT, Head of CMC
Vice President, Clinical Operations

Board & advisors

Founder
Co-Founder & Co-Chair, Scientific Advisory Board
Scientific Advisor
Founding Advisor